These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12732912)

  • 1. Measles control in NSW divisions of general practice.
    MacIntyre CR; Hull B; Burgess M; Gay N
    N S W Public Health Bull; 2003; 14(1-2):13-7. PubMed ID: 12732912
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping immunisation coverage and conscientious objectors to immunisation in NSW.
    Hull B; McIntyre P
    N S W Public Health Bull; 2003; 14(1-2):8-12. PubMed ID: 12732911
    [No Abstract]   [Full Text] [Related]  

  • 3. Factsheet: measles.
    N S W Public Health Bull; 2012 Dec; 23(9-10):209. PubMed ID: 23442999
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
    Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
    [No Abstract]   [Full Text] [Related]  

  • 5. IAP perspectives on measles and rubella elimination strategies.
    Vashishtha VM; Yewale VN; Bansal CP; Mehta PJ;
    Indian Pediatr; 2014 Sep; 51(9):719-22. PubMed ID: 25228604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 7. EpiReview: Measles in NSW, 2002-2011.
    Rosewell A; Reinten-Reynolds T; Spokes PJ
    N S W Public Health Bull; 2012 Dec; 23(9-10):201-7. PubMed ID: 23442997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "We can consign this nasty infection to the history books".
    Bedford H
    Nurs Times; 2011 Jul 26-Aug 1; 107(29):13. PubMed ID: 21941728
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trend of measles, mumps, and rubella incidence following the measles-rubella catch up vaccination in the Republic of Korea, 2001.
    Choe YJ; Eom HE; Cho SI
    J Med Virol; 2017 Sep; 89(9):1528-1531. PubMed ID: 28303592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timeliness of MMR vaccination--influence on vaccination coverage.
    Dannetun E; Tegnell A; Hermansson G; Törner A; Giesecke J
    Vaccine; 2004 Oct; 22(31-32):4228-32. PubMed ID: 15474712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMR vaccine at 9 months: authors reply.
    Vashishtha VM
    Indian Pediatr; 2015 Jan; 52(1):81-2. PubMed ID: 25638203
    [No Abstract]   [Full Text] [Related]  

  • 14. Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: issues and concerns.
    Bhatnagar N; Kaur R; Gupta M; Sharma D
    Indian Pediatr; 2014 Jun; 51(6):441-3. PubMed ID: 24986275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal.
    Gonçalves G; Frade J; Nunes C; Mesquita JR; Nascimento MS
    Vaccine; 2015 Sep; 33(39):5057-63. PubMed ID: 26319061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMR at 9 months: rushing in where others fear to tread?
    Sharma A; Puliyel J
    Indian Pediatr; 2015 Jan; 52(1):80-1. PubMed ID: 25638202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(9):190-1. PubMed ID: 11905460
    [No Abstract]   [Full Text] [Related]  

  • 20. Options for improvement of the Dutch measles vaccination schedule.
    van den Hof S; Wallinga J; Widdowson MA; Conyn-van Spaendonck MA
    Vaccine; 2003 Jan; 21(7-8):721-4. PubMed ID: 12531348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.